ERBB2 and breast carcinoma: Compared to that of the SEER-21 (2014–2018) data, breast cancers in the WTC EHC had higher proportion of luminal B (10% and 15%, respectively), triple-negative (10% and 13%, respectively), and HER-2-enriched (4% and 7%, respectively) subtypes (as illustrated in Table 3).